Shares of Taysha Gene Therapies, Inc. (NASDAQ: TSHA) rose sharply in today’s pre-market trading after the company reported a year-over-year increase in FY23 EPS results.
The company reported fiscal year 2023 losses of 96 cents per share, compared to losses of $3.78 per share from the prior year. Taysha reported it had $143.9 million in cash and cash equivalents on Dec. 31, 2023.
The company also provided clinical updates including the completed dosing in cohort one of its REVEAL Phase 1/2 adolescent and adult trial and the expansion of the ongoing trial in Canada into the U.S. and initiated site activation.
Taysha Gene Therapies shares jumped 27.1% to $2.86 in pre-market trading
Here are some other stocks moving in pre-market trading.
Gainers
ETAO International Co., Ltd. (NASDAQ: ETAO) shares rose 200.4% to $0.4296 in pre-market trading. The company announced a reverse stock split.
Oblong, Inc. (NASDAQ: OBLG) rose 48.2% to $0.20 in pre-market trading after the company reported financial results for fourth quarter 2023 and issued a business update.
BYND Cannasoft Enterprises Inc. (NASDAQ: BCAN) climbed 44% to $0.0288 in pre-market trading after falling 15% on Tuesday. ...
Benzinga
ContextLogic Inc. Class A